JPRN-UMIN000002528已完成4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney disease - Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney disease
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2009年9月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of hypersensitivity to ezechimibe 2. Dialysis patients 3. Severe liver disease 4. Secondary or drug-induced hypercholesterolemia 5. Pregnant or nursing women or women suspect of pregnancy 6. Judged as inappropriate for study by doctor
研究者
相似试验
已完成
不适用
Beneficial effects of cholesterol absorption inhibitor,ezetimibe on impaired endothelial function in patients with metabolic syndrome.Metabolic syndromeJPRN-UMIN000001305Tohoku University Graduate School of Medicine EZET-trial group60
已完成
不适用
The study about the effects of cholesterol absorption inhibition on coronary artery plaque in patients treated with PCIcoronary artery diseasesJPRN-UMIN000026581Kurume University Medical Center50
尚未招募
不适用
Cholesterol Absorption Inhibition Study in humans after single intake of cholesterol lowering margarine, Unilever Study 09030-V, Study name: CASTEmild hypercholesterolemiaslightly elevated cholesterol10013317NL-OMON34622nilever18
已完成
4 期
Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction after Coronary Stenting, A Randomized Controlled TrialJPRN-UMIN000005597Department of Cardiovascular Medicine Kyushu University Graduate School of Medical Sciences260
已完成
不适用
Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseasesJPRN-UMIN000030635Osaka City University3,000